Cancer Therapy South Portland ME

Cancer can affect every part of the body. Cancer treatment varies widely and may include anti-cancer drugs, radiation therapy, chemotherapy, surgery, biological therapies, bone marrow transplantations, targeted cancer therapies, and others. See below to learn more and to gain access to oncologists in South Portland, ME who provide cancer therapy.

Marjorie Ann Boyd
(207) 774-5662
19 Bramhall St
Portland, ME
Specialty
Hematology, Hematology / Oncology

Data Provided by:
Cornelius John McGinn, MD
(207) 871-2276
22 Bramhall St
Portland, ME
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Vt Coll Of Med, Burlington Vt 05405
Graduation Year: 1989

Data Provided by:
Anna Halina Niegowska, MD
(207) 879-3030
144 State St
Portland, ME
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Akademia Med, Lublin, Poland
Graduation Year: 1989

Data Provided by:
Roger Charles Inhorn, MD
(207) 879-3030
144 State St Fl 4
Portland, ME
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Washington Univ Sch Of Med, St Louis Mo 63110
Graduation Year: 1990

Data Provided by:
Louis G Bove, MD
(207) 207-7740
32 Penrith Rd
Portland, ME
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Cornell Univ Med Coll, New York Ny 10021
Graduation Year: 1952

Data Provided by:
Stuart Gary Gilbert, MD
(207) 885-7750
22 Bramhall St
Portland, ME
Specialties
Oncology (Cancer), Radiation Oncology, Diagnostic Radiology
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1966
Hospital
Hospital: Maine Med Ctr, Portland, Me
Group Practice: Spectrum Medical Group; Spectrum Medical Group At Maine Med Ctr Scarborough

Data Provided by:
Sarah Allen Thurman, MD
(207) 871-2276
22 Bramhall St
Portland, ME
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Univ Of Va Sch Of Med, Charlottesville Va 22908
Graduation Year: 1996

Data Provided by:
Charles Kazuto Tashima, MD
(207) 879-3030
144 State St
Portland, ME
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1956
Hospital
Hospital: Central Maine Med Ctr, Lewiston, Me
Group Practice: St Mary's Hematology/Oncology

Data Provided by:
Ian J Bristol
(207) 662-2276
22 Bramhall St
Portland, ME
Specialty
Radiation Oncology

Data Provided by:
Laurie Ann Small, MD
(207) 761-0125
887 Congress St Ste 100
Portland, ME
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Data Provided by:

Female Dangers

While breast cancer is the biggest and most publicized cancer threat American
women face, it is not the only female-specific cancer. Cervical, ovarian and uterine
malignancies affect thousands each year. Learn what to look out for so you don’t fall victim.

By Lisa James

May 2006

If someone says the words “female” and “cancer” to you, the first word that probably pops into your head is “breast.” After all, the numbers are hard to ignore: Almost 213,000 American women develop breast malignancies each year…and more than 40,000 die from them.

But a woman overlooks her reproductive tract at her peril; just ask actress Fran Drescher, who graced the cover of last year’s Annual ET Cancer Issue. In her book, Cancer Schmancer (Warner Books), Drescher explains how she saw nine doctors—count ’em, nine—before her uterine cancer was finally discovered and treated, leaving her unable to bear children. “Women need to understand gynecological cancers and the tests that can help detect them,” she writes. “We have to…become educated consumers, network among ourselves, and gain information and insight into getting diagnosed and getting treatment. Someone gimme a podium!”

Taking our lead from “The Nanny,” ET presents what you need to know about three cancers—cervical, ovarian and uterine—that should be on every woman’s radar. (Statistics given are 2006 estimates from the American Cancer Society [ACS].)

Uterine Cancer: A Hormonal Challenge

What it is: Most are endometrial cancers; they arise in the inner lining (endometrium) of the uterus, the part that grows and is shed over the course of a woman’s menstrual cycle. Tumors called sarcomas can develop in the muscle tissue, but account for only 2% to 4% of all uterine cancers.
Number of women affected: 41,200 cases of endometrial cancer (the most common reproductive-tract malignancy) and 7,350 deaths. It is one of the more treatable cancers though, with a five-year survival rate of 84%.

At greatest risk: Roughly 70% of all women affected are between the ages of 45 and 74. Endometrial cancer shares a lot of risk factors with ovarian cancer because excessive estrogen exposure promotes overgrowth of the uterine lining. Taking the drug tamoxifen for breast cancer also increases risk, as does having undergone pelvic radiation therapy. Genetic history is another factor, particularly in families affected by hereditary nonpolyposis colon cancer (HNPCC).

The symptoms: Abnormal bleeding, especially after menopause. Pain and weight loss can be signs of late-stage disease.

The tests: There are no standard screening tests for this kind of cancer. Abnormal bleeding may prompt your doctor to perform an endometrial biopsy, in which a thin needle is passed through the cervical opening to collect cells in the uterine lining.

Vital info: Try your best to drop those extra pounds. Obesity ups the risk of hormonally driven cancers because fat tissue can transform other hormones into estr...

Click here to read the rest of this article from Energy Times